HomeXTCY • CNSX
add
Xtacy Therapeutics Corp
Previous close
$0.045
Day range
$0.050 - $0.050
Year range
$0.020 - $0.12
Market cap
2.46M CAD
Avg Volume
12.30K
P/E ratio
-
Dividend yield
-
Primary exchange
CNSX
Market news
Financials
Income Statement
Revenue
Net income
(CAD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 250.78K | 83.91% |
Net income | -265.84K | -74.21% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(CAD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | — | — |
Total assets | 332.48K | 48.62% |
Total liabilities | 665.96K | -15.59% |
Total equity | -333.48K | — |
Shares outstanding | 54.58M | — |
Price to book | -4.50 | — |
Return on assets | -179.14% | — |
Return on capital | 197.27% | — |
Cash Flow
Net change in cash
(CAD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -265.84K | -74.21% |
Cash from operations | 0.00 | -100.00% |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | 107.43K | 143.22% |
About
Founded
1998
Headquarters
Website